Abstract
This thesis describes studies on drug exposure, safety management and intervention methods in the chemotherapeutic drugs capecitabine and paclitaxel, and in tyrosine kinase inhibitors (in particular sorafenib), with the aim to improve control over these side effects.
Original language | English |
---|---|
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 15 Jun 2022 |
Place of Publication | Rotterdam |
Print ISBNs | 978-94-6361-679-9 |
Publication status | Published - 15 Jun 2022 |